APA (7th ed.) Citation

LoRusso, P. M., Infante, J. R., Kim, K. B., Burris, H. A., Curt, G., Emeribe, U., . . . Emeribe, U. (2017). A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. BMC Cancer, 17, 1. https://doi.org/10.1186/s12885-017-3143-6

Chicago Style (17th ed.) Citation

LoRusso, Patricia M., et al. "A Phase I Dose-escalation Study of Selumetinib in Combination with Docetaxel or Dacarbazine in Patients with Advanced Solid Tumors." BMC Cancer 17 (2017): 1. https://doi.org/10.1186/s12885-017-3143-6.

MLA (9th ed.) Citation

LoRusso, Patricia M., et al. "A Phase I Dose-escalation Study of Selumetinib in Combination with Docetaxel or Dacarbazine in Patients with Advanced Solid Tumors." BMC Cancer, vol. 17, 2017, p. 1, https://doi.org/10.1186/s12885-017-3143-6.